(Q43353269)

20 November 2017

title

LC determination of oxcarbazepine and its active metabolite in human serum (English)

1 reference

20 November 2017

H Levert

1

1 reference

20 November 2017

P Odou

series ordinal

2

1 reference

20 November 2017

H Robert

series ordinal

3

1 reference

20 November 2017

publication date

1 May 2002

1 reference

20 November 2017

number of pages

9

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

20 November 2017

volume

28

1 reference

20 November 2017

issue

3-4

1 reference

20 November 2017

page(s)

517-525

1 reference

The new generation of antiepileptic drugs: advantages and disadvantages

20 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Pharmacokinetics of new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

New drugs for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Dose dependent enzyme induction by oxcarbazepine?

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Oxcarbazepine: pharmacokinetic interactions and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Clinical pharmacology and pharmacokinetics of oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Automated microanalysis of oxcarbazepine and its monohydroxy and transdiol metabolites in plasma by liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Rapid micromethod for simultaneous measurement of oxcarbazepine and its active metabolite in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2801%2900684-7

7 January 2021

10.1016/S0731-7085(01)00684-7

Identifiers

DOI

1 reference

20 November 2017

1 reference